A novel
therapeutic hepatitis B vaccine induces cellular and humoral immune responses and breaks tolerance in hepatitis B virus (HBV) transgenic mice (2013).
Buchmann P, Dembek C, Kuklick L, Jäger C, Tedjokusumo R, von Freyend MJ, Drebber U, Janowicz Z, Melber K, Protzer U.
Source
Rhein Biotech GmbH, Duesseldorf, Germany. ***@****
Abstract
Therapeutic vaccines are currently being developed for chronic hepatitis B and C.